Blog
RSS FeedPosted by Michael Wonder on 28 Aug 2019
Placebos and blinding in randomised controlled cancer clinical trials for drug and biological products: guidance for industry
28 August 2019 - This guidance provides recommendations to industry about the use of placebos and blinding in randomised controlled clinical ...
Posted by Michael Wonder on 28 Aug 2019
Dutch health minister threatens to name and shame pharma over prices
28 August 2019 - In an unusual move, the Netherlands health minister wrote an open letter to the pharmaceutical industry ...
Posted by Michael Wonder on 28 Aug 2019
Dutch minister warns big pharma to come clean on drugs prices
27 August 2019 - Health minister Bruno Bruins has warned the pharmaceuticals industry that he considers the way drugs firms ...
Posted by Michael Wonder on 20 Aug 2019
Brand name drug prices rising at slower pace, lower amounts
20 August 2019 - Drug companies are still raising prices for brand-name prescription medicines, just not as often or by ...
Posted by Michael Wonder on 13 Aug 2019
Why America’s biggest charities are owned by pharmaceutical companies
13 August 2019 - Their generosity helps their bottom line. ...
Posted by Michael Wonder on 08 Aug 2019
AstraZeneca CEO on drug prices: the system has to change
8 August 2019 - As part of the Trump administration’s broader efforts to reform health care, President Trump has lead ...
Posted by Michael Wonder on 30 Jul 2019
Pharma leaders: support the social contract on drug prices
30 July 2019 - When I was 13 years old, my doctor told me I had Crohn’s disease, a painful ...
Posted by Michael Wonder on 26 Jul 2019
Intellectual property law amends will add to business uncertainty
26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...
Posted by Michael Wonder on 25 Jul 2019
Trump meets with pharma executives amid drug pricing push
25 July 2019 - President Trump on Wednesday met with pharmaceutical executives at the White House as the industry fights ...
Posted by Michael Wonder on 23 Jul 2019
Drug maker group boosts lobbying as push to lower prices stalls
23 July 2019 - Top companies also report higher spending in second quarter. ...
Posted by Michael Wonder on 22 Jul 2019
PhRMA scrambles to fight potential drug pricing reforms in budget deal
19 July 2019 - The drug industry’s lobbying group is calling on its lobbyists to push back on a potential ...
Posted by Michael Wonder on 16 Jul 2019
How pharma, under attack from all sides, keeps winning in Washington
16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...
Posted by Michael Wonder on 16 Jul 2019
Rick Scott: PhRMA hasn't provided 'a single answer' on lower drug prices
15 July 2019 - Senator Rick Scott (R-Fla.) is calling out the Pharmaceutical Research and Manufacturers of America (PhRMA), accusing ...
Posted by Michael Wonder on 10 Jul 2019
Drug makers boost prices up to 909%, defying political pressure
10 July 2019 - Bipartisan efforts to lower drug prices in Washington have not prevented drugmakers from going about their ...
Posted by Michael Wonder on 09 Jul 2019
GSK welcomes the UK trial of subscription-style payment system for pharma companies to incentivise creation of new antibiotics
9 July 2019 - GSK is committed to tackling antimicrobial resistance as part of a sustained, multi-stakeholder response to this global ...